Genetic Polymorphism and Tumor Immunotherapy
Journal:
Current Pharmacogenomics
Volume:
1
Page:
37-57
Author(s):
Rongcun Yang and Richard B.S. Roden
Genomic and Proteomic Techniques and their Application in Selenium Research
Journal:
Current Pharmacogenomics
Volume:
1
Page:
59-65
Author(s):
Huawei Zeng
Resveratrol and Cancer: Chemoprevention, Apoptosis, and Chemoimmunosensitizing Activities
Journal:
Current Medicinal Chemistry - Anti-Cancer Agents
Volume:
3
Page:
77-93
Author(s):
C. Cal, H. Garban, A. Jazirehi, C. Yeh, Y. Mizutani and B. Bonavida
New Approach to Cancer Therapy: The Application of Signal Transduction to Anti-Cancer Drug
Journal:
Current Medicinal Chemistry - Anti-Cancer Agents
Volume:
3
Page:
119-131
Author(s):
Shinji Osada and Shigetoyo Saji
Second Generation Taxanes: from the Natural Framework to the Challenge of Drug Resistance
Journal:
Current Medicinal Chemistry - Anti-Cancer Agents
Volume:
3
Page:
133-138
Author(s):
Cristiano Ferlini, Iwao Ojima, Mariagrazia Distefano, Daniela Gallo, Antonella Riva, Paolo Morazzoni, Ezio Bombardelli, Salvatore Mancuso and Giovanni Scambia
Glucuronides in Anti-Cancer Therapy
Journal:
Current Medicinal Chemistry - Anti-Cancer Agents
Volume:
3
Page:
139-150
Author(s):
Xi Chen, Bingyuan Wu and Peng George Wang
Human Kallikreins: Common Structural Features, Sequence Analysis and Evolution
Journal:
Current Genomics
Volume:
4
Page:
147-165
Author(s):
George M. Yousef and Eleftherios P. Diamandis
Assessment of Gene Transfer Using Imaging Methodology
Journal:
Current Genomics
Volume:
4
Page:
167-184
Author(s):
Annette Altmann and Uwe Haberkorn
Receptor Tyrosine Kinases: The Main Targets for New Anticancer Therapy
Journal:
Current Drug Targets
Volume:
4
Page:
113-121
Author(s):
Joachim Drevs, Michael Medinger, Carmen Schmidt-Gersbach, Renate Weber and Clemens Unger
Integrin αvβ3 as a Therapeutic Target for Blocking Tumor-Induced Angiogenesis
Journal:
Current Drug Targets
Volume:
4
Page:
123-131
Author(s):
C. Chandra Kumar